OSE Immunotherapeutics Strengthens Leadership Team with the Appointment of Laurence de Schoulepnikoff as Chief Business Officer

Steven Spielberg

In Addition, Three Senior Executives Will Reinforce the Company’s Drug Development Engine NANTES, France, December 20, 2021–(BUSINESS WIRE)–Regulatory News: OSE Immunotherapeutics SA (Paris:OSE) (ISIN: FR0012127173; Mnemo: OSE) announces the appointment of Laurence de Schoulepnikoff as Chief Business Officer (CBO), as well as three senior appointments to further strengthen the OSE […]

Subscribe US Now